NY State Approved Indicates the status of NY State approval and if the test is orderable for NY State clients.
Monitoring citalopram therapy
While regular blood level monitoring is not indicated in most patients, the test is useful to identify noncompliance
When used in conjunction with CYP 2C19 and CYP 3A4-5 genotyping, the test can identify states of altered drug metabolism
Liquid Chromatography-Tandem Mass Spectrometry (LC-MS/MS)
Reporting Name A shorter/abbreviated version of the Published Name for a test; an abbreviated test name